Procter & Gamble Hygiene and Health Care (500459) Q1 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 25/26 earnings summary
15 Dec, 2025Executive summary
Unaudited financial results for the quarter ended June 30, 2025, were approved and reviewed by the Board and Audit Committee.
Financials prepared in accordance with Ind AS 34 and SEBI regulations.
Financial highlights
Revenue from operations for the quarter was ₹93,516 lakhs, compared to ₹93,703 lakhs in the previous quarter and ₹94,472 lakhs in the same quarter last year.
Profit before tax for the quarter was ₹26,470 lakhs, up from ₹21,266 lakhs in the previous quarter and ₹11,228 lakhs year-over-year.
Net profit for the quarter was ₹19,206 lakhs, compared to ₹15,610 lakhs in the previous quarter and ₹8,106 lakhs in the same quarter last year.
Basic and diluted EPS for the quarter stood at ₹59.17, up from ₹48.09 in the previous quarter and ₹24.97 year-over-year.
Outlook and guidance
The company changed its financial year-end from June 30 to March 31, with the previous financial year covering nine months from July 1, 2024, to March 31, 2025.
Latest events from Procter & Gamble Hygiene and Health Care
- Strong growth, innovation, and digital expansion drive positive outlook.500459
Investor Update3 Feb 2026 - Strong quarterly growth and a special dividend highlight robust performance.500459
Q3 25/2630 Jan 2026 - 9-month profit after tax reached ₹637 crore, with EPS at ₹196.11 and ₹175 per share dividend declared.500459
Q4 24/2519 Jan 2026 - Q2 FY25 saw strong revenue and profit growth, with EPS up to ₹65.28.500459
Q2 24/2515 Dec 2025 - Quarterly net profit reached ₹21,190 lakhs with EPS of ₹64.65 and strong cash reserves.500459
Q2 25/2615 Dec 2025 - Strong revenue and profit growth with a ₹110 interim dividend and a shift to a March 31 year-end.500459
Q3 24/2515 Dec 2025